Patient-reported barriers to dietary adherence in heart failure: a qualitative substudy of the Pro-HEART trial.

Eur J Cardiovasc NursSep 8, 2026
Clinical ResearchCardiologyGastroenterology

Andrew T Reyes, Angelina Nguyen, Alona D Angosta et al.

✦ AI-curated · Sources linked

In 30 seconds

This qualitative substudy of the Pro-HEART randomized controlled trial examined barriers to dietary adherence in 24 participants with heart failure during a 12-week weight-loss phase. Key findings revealed that psychological distress, tracking burden, and cultural dissonance significantly hindered adherence to dietary prescriptions, highlighting the complexity of patient experiences in nutrition interventions.

Key findings

  • Participants reported psychological distress due to guilt and fear of failure.
  • Tracking burden was noted from extensive weighing and logging of food.
  • Cultural dissonance arose from a mismatch between meal plans and traditional food practices.
  • Social pressures from family dynamics and events contributed to decreased motivation.

Why it matters

Understanding patient-reported barriers to dietary adherence is crucial for developing effective, patient-centered nutrition interventions in heart failure management. Addressing these barriers can enhance adherence and improve health outcomes.

Source

PubMed · PMID 41911329

Published in Eur J Cardiovasc Nurs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Clinical ResearchOncology (Medical)

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

This phase 3 randomized clinical trial evaluated the efficacy and safety of osimertinib combined with chemotherapy versus osimertinib alone in 294 patients with advanced non-small cell lung cancer (NSCLC) harboring…

JAMASep 8, 2026Open accessRead summary
Clinical ResearchHematology

Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

This phase 2 randomized trial compared azacitidine plus venetoclax to induction chemotherapy in 172 previously untreated adults with acute myeloid leukemia (AML) eligible for induction.

N Engl J MedSep 3, 2026Read summary
Clinical ResearchPsychiatry

The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial.

This randomized controlled trial evaluated the efficacy of Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S) combined with treatment as usual (TAU) in 130 outpatients with schizophrenia-spectrum disorders…

Lancet PsychiatrySep 10, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.